Developer docs
API playgroundTry for free, no card

Search company profiles

Cell & Gene

Full company profile

uuid000mw1c

Namestring
Cell & Gene
Legal namestring
VertMarkets, Inc.
Websiteurl
cellandgene.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Cell & Gene is a B2B media and content platform serving the cell and gene therapy (CGT) industry, operated as a publication brand under VertMarkets, Inc., a life science B2B media conglomerate headquartered in Erie, Pennsylvania. The platform delivers industry-specific editorial covering CGT manufacturing, vectors, formulation, fill-finish, cold chain management, and quality control, and serves pharmaceutical and biotech developers, contract development and manufacturing organizations (CDMOs), and equipment and service suppliers operating in the advanced therapies space. Cell & Gene positions itself as a centralized information hub for a fast-growing and technically complex sector, with the global CGT market projected to reach $28.05 billion by 2031 at a 25.8% CAGR.

The core product is a multi-channel content portfolio: a free weekly email newsletter, the on-demand STREAM Video Channel, Cell & Gene Live virtual events, the Cell & Gene: The Podcast audio series, the annual Cell & Gene Tech Expo, cur ated Content Collections, and Sourcing Centers — a B2B directory platform connecting developers with service providers across clinical trial services, manufacturing, regulatory, supply chain, outsourcing, and translational research categories. The underlying technology is a web-based content management and digital publishing platform, and the brand is embedded within the broader Life Science Connect network of 12+ peer B2B publications that cross-promote content and share audience reach.

The business model is advertising- and sponsorship-supported rather than subscription-based. Revenue is generated primarily from display advertising and sponsored content sold to CGT industry suppliers, CDMOs, and life science service providers; from event sponsorships and registrations (CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, Tech Expo); and from supplier directory listings on the Sourcing Centers. The free newsletter serves as audience-building and lead-generation infrastructure, creating the reach that advertisers and sponsors purchase against.

Short descriptiontext

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry, delivering editorial articles, newsletters, podcasts, video, virtual events, and a sourcing directory to CGT developers, CDMOs, and life science suppliers, monetized through advertising, sponsorships, and event registrations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersErie, United States
HQ citystring
Erie
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
B2B media publishing, cell therapy content, gene therapy news, life science events, CDMO industry coverage
NAICS code1 code
  • Directory and Mailing List Publishers513140
SIC code1 code
  • Miscellaneous Publishing2741
Product category
B2B Industry Media
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Advertising & Sponsorship Revenue
TypeAdvertising
Description

Cell & Gene generates revenue primarily through advertising and sponsorship from life science industry suppliers, CDMOs, equipment manufacturers, and service providers seeking to reach the CGT professional audience. The platform offers premier advertiser partnerships and media kit options for companies wanting to promote their products and services to the industry.

cellandgene.com
2Newsletter Subscription (Free to Readers)
TypeFreemium
Description

The company offers free newsletter subscriptions to industry professionals as a lead generation and audience building mechanism. This free model drives audience growth and creates advertising inventory for sponsors targeting the CGT industry.

cellandgene.com
3Event Sponsorships and Registrations
TypeProfessional Services
Description

Revenue generated from sponsored sessions, booth placements, and registrations at owned events including CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, and the Cell & Gene Tech Expo.

cellandgene.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure
Pricing details1 tier
1Free newsletter subscription for industry professionals
ModelFreemiumBilling cadenceMonthly
Notes

Free newsletter signup available to industry professionals. The subscription provides ongoing industry insights, news, and featured editorial content at no cost to subscribers.

cellandgene.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1STREAM Video Channel
Description

Video content platform featuring webinars and educational content on cell and gene therapy manufacturing and development

cellandgene.com
+3 more records
Core offering1 text field

Cell & Gene is a B2B media and content platform dedicated to the cell and gene therapy industry. It publishes editorial articles, technical guides, white papers, a weekly email newsletter, on-demand video content, a podcast, and live virtual events, and hosts an annual expo plus Sourcing Center B2B directories for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research services. Revenue is generated through advertising, sponsorships, and event participation by CDMOs, equipment manufacturers, and life science service providers targeting CGT professionals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry. The platform operates as a unified offering combining multiple content channels: the Cell & Gene Newsletter (weekly industry insights), STREAM Video Channel (on-demand webinars), Cell & Gene Live (virtual events), Cell & Gene: The Podcast (audio discussions), and Cell & Gene Tech Expo (annual conference). The platform also hosts Content Collections (curated editorial packages) and Sourcing Centers (B2B directories connecting manufacturers with service providers for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research). The site publishes educational topic pages covering CGT Vectors, Cell Therapy Manufacturing, Gene Therapy Manufacturing, Formulation, Fill-Finish, Quality Assurance, and Cold Chain Management.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

VertMarkets, Inc. is the parent company and publisher of Cell & Gene. The company operates as part of the VertMarkets media network, which has been serving the life science industry since 1996. VertMarkets publishes multiple B2B industry publications across pharmaceutical, biotech, medical device, and life science sectors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Life Science Connect network is a consortium of B2B publications serving the life science industry, including Cell & Gene, Advancing RNA, Bioprocess Online, Biosimilar Development, Clinical Leader, Clinical Supply Leader, Drug Delivery Leader, Drug Discovery Online, Life Science Leader, Med Device Online, Outsource Pharma, and Pharmaceutical Online. These publications cross-promote content and share audience reach to benefit member publications and their advertisers.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Independent B2B news outlet covering the biopharma industry with significant overlap into cell and gene therapy reporting, manufacturing, and CDMO deal coverage. Direct competitor for CGT professional audience attention and biopharma advertising dollars.

2GEN (Genetic Engineering & Biotechnology News)
TypeDirect peer
Description

Long-running B2B publication covering biotechnology, with extensive cell and gene therapy editorial coverage including manufacturing, vectors, and bioprocessing. Direct competitor for the same CGT professional subscriber and advertiser base.

TypeDirect peer
Description

Industry publication covering biopharma business, R&D, and manufacturing trends including CGT. Comparable B2B media model relying on advertising, newsletters, and events for the same life science professional audience.

TypeDirect peer
Description

Major biopharma trade publication covering clinical development, manufacturing, and deal activity in cell and gene therapy. Competes directly for CGT professional readership and advertising spend.

TypeDirect peer
Description

Life sciences industry news and career platform with dedicated CGT manufacturing and bioprocessing coverage. Comparable B2B media + community model serving the same hiring and product-awareness audiences.

TypeDirect peer
Description

Vertically-focused B2B publication and conference series covering bioprocessing, including cell and gene therapy manufacturing. Most direct overlap in CGT manufacturing editorial and CDMO audience.

TypeBroad incumbent
Description

Sister publication within the same Life Science Connect / VertMarkets network. Covers contract manufacturing and outsourcing broadly across pharma, including CGT, and shares audiences and advertiser pools with Cell & Gene.

TypeBroad incumbent
Description

Sister publication within the Life Science Connect network covering drug discovery, with adjacent CGT therapeutic content. Comparable business model and shared cross-promotion.

TypeBroad incumbent
Description

VertMarkets/Life Science Connect publication covering the broader life science executive audience, including CGT operations. Comparable B2B media model within the same parent network.

TypeRegional player
Description

UK-based B2B pharma publication covering manufacturing, clinical development, and industry trends including CGT. Comparable B2B media format but primarily focused on European audiences.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cell & Gene

B2B Industry Mediacellandgene.com

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry, delivering editorial articles, newsletters, podcasts, video, virtual events, and a sourcing directory to CGT developers, CDMOs, and life science suppliers, monetized through advertising, sponsorships, and event registrations.

What Cell & Gene does

Cell & Gene is a B2B media and content platform serving the cell and gene therapy (CGT) industry, operated as a publication brand under VertMarkets, Inc., a life science B2B media conglomerate headquartered in Erie, Pennsylvania. The platform delivers industry-specific editorial covering CGT manufacturing, vectors, formulation, fill-finish, cold chain management, and quality control, and serves pharmaceutical and biotech developers, contract development and manufacturing organizations (CDMOs), and equipment and service suppliers operating in the advanced therapies space. Cell & Gene positions itself as a centralized information hub for a fast-growing and technically complex sector, with the global CGT market projected to reach $28.05 billion by 2031 at a 25.8% CAGR.

The core product is a multi-channel content portfolio: a free weekly email newsletter, the on-demand STREAM Video Channel, Cell & Gene Live virtual events, the Cell & Gene: The Podcast audio series, the annual Cell & Gene Tech Expo, cur ated Content Collections, and Sourcing Centers — a B2B directory platform connecting developers with service providers across clinical trial services, manufacturing, regulatory, supply chain, outsourcing, and translational research categories. The underlying technology is a web-based content management and digital publishing platform, and the brand is embedded within the broader Life Science Connect network of 12+ peer B2B publications that cross-promote content and share audience reach.

The business model is advertising- and sponsorship-supported rather than subscription-based. Revenue is generated primarily from display advertising and sponsored content sold to CGT industry suppliers, CDMOs, and life science service providers; from event sponsorships and registrations (CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, Tech Expo); and from supplier directory listings on the Sourcing Centers. The free newsletter serves as audience-building and lead-generation infrastructure, creating the reach that advertisers and sponsors purchase against.

Cell & Gene firmographics

Firmographics
Name
Cell & Gene
Legal name
VertMarkets, Inc.
Website
https://cellandgene.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
1–10 employees
Short description
Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry, delivering editorial articles, newsletters, podcasts, video, virtual events, and a sourcing directory to CGT developers, CDMOs, and life science suppliers, monetized through advertising, sponsorships, and event registrations.
Ownership category
akta.pro rank

Where Cell & Gene is headquartered

Location

Headquarters

HQ city
Erie
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cell & Gene business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Advertising & Sponsorship Revenue: Cell & Gene generates revenue primarily through advertising and sponsorship from life science industry suppliers, CDMOs, equipment manufacturers, and service providers seeking to reach the CGT professional audience. The platform offers premier advertiser partnerships and media kit options for companies wanting to promote their products and services to the industry.
  2. Newsletter Subscription (Free to Readers): The company offers free newsletter subscriptions to industry professionals as a lead generation and audience building mechanism. This free model drives audience growth and creates advertising inventory for sponsors targeting the CGT industry.
  3. Event Sponsorships and Registrations: Revenue generated from sponsored sessions, booth placements, and registrations at owned events including CDMO Leadership Awards, CDMO Live Americas, CDMO Live Europe, and the Cell & Gene Tech Expo.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree newsletter subscription for industry professionals

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Cell & Gene product offering

Product offering

Core offering

Cell & Gene is a B2B media and content platform dedicated to the cell and gene therapy industry. It publishes editorial articles, technical guides, white papers, a weekly email newsletter, on-demand video content, a podcast, and live virtual events, and hosts an annual expo plus Sourcing Center B2B directories for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research services. Revenue is generated through advertising, sponsorships, and event participation by CDMOs, equipment manufacturers, and life science service providers targeting CGT professionals.

Product overview

Cell & Gene is a B2B media and content platform serving the cell and gene therapy industry. The platform operates as a unified offering combining multiple content channels: the Cell & Gene Newsletter (weekly industry insights), STREAM Video Channel (on-demand webinars), Cell & Gene Live (virtual events), Cell & Gene: The Podcast (audio discussions), and Cell & Gene Tech Expo (annual conference). The platform also hosts Content Collections (curated editorial packages) and Sourcing Centers (B2B directories connecting manufacturers with service providers for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research). The site publishes educational topic pages covering CGT Vectors, Cell Therapy Manufacturing, Gene Therapy Manufacturing, Formulation, Fill-Finish, Quality Assurance, and Cold Chain Management.

Differentiator

Problem solved

Functional benefit

Brands

  • STREAM Video Channel: Video content platform featuring webinars and educational content on cell and gene therapy manufacturing and development
  • Cell & Gene Live
  • Cell & Gene: The Podcast
  • Cell & Gene Tech Expo

Companies that use Cell & Gene

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Cell & Gene technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Cell & Gene partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • VertMarkets, Inc.coreOthersVertMarkets, Inc. is the parent company and publisher of Cell & Gene. The company operates as part of the VertMarkets media network, which has been serving the life science industry since 1996. VertMarkets publishes multiple B2B industry publications across pharmaceutical, biotech, medical device, and life science sectors.
  • Life Science Connect NetworkcoreStrategic or Co-development PartnerThe Life Science Connect network is a consortium of B2B publications serving the life science industry, including Cell & Gene, Advancing RNA, Bioprocess Online, Biosimilar Development, Clinical Leader, Clinical Supply Leader, Drug Delivery Leader, Drug Discovery Online, Life Science Leader, Med Device Online, Outsource Pharma, and Pharmaceutical Online. These publications cross-promote content and share audience reach to benefit member publications and their advertisers.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Cell & Gene competitors and assessment

Company assessment

Direct peers

  • Endpoints News: Independent B2B news outlet covering the biopharma industry with significant overlap into cell and gene therapy reporting, manufacturing, and CDMO deal coverage. Direct competitor for CGT professional audience attention and biopharma advertising dollars.
  • GEN (Genetic Engineering & Biotechnology News): Long-running B2B publication covering biotechnology, with extensive cell and gene therapy editorial coverage including manufacturing, vectors, and bioprocessing. Direct competitor for the same CGT professional subscriber and advertiser base.
  • BioPharma Dive: Industry publication covering biopharma business, R&D, and manufacturing trends including CGT. Comparable B2B media model relying on advertising, newsletters, and events for the same life science professional audience.
  • Fierce Biotech: Major biopharma trade publication covering clinical development, manufacturing, and deal activity in cell and gene therapy. Competes directly for CGT professional readership and advertising spend.
  • BioSpace: Life sciences industry news and career platform with dedicated CGT manufacturing and bioprocessing coverage. Comparable B2B media + community model serving the same hiring and product-awareness audiences.
  • BioProcess International (BPI): Vertically-focused B2B publication and conference series covering bioprocessing, including cell and gene therapy manufacturing. Most direct overlap in CGT manufacturing editorial and CDMO audience.

Broad incumbents

  • Outsourced Pharma: Sister publication within the same Life Science Connect / VertMarkets network. Covers contract manufacturing and outsourcing broadly across pharma, including CGT, and shares audiences and advertiser pools with Cell & Gene.
  • Drug Discovery Online: Sister publication within the Life Science Connect network covering drug discovery, with adjacent CGT therapeutic content. Comparable business model and shared cross-promotion.
  • Life Science Leader: VertMarkets/Life Science Connect publication covering the broader life science executive audience, including CGT operations. Comparable B2B media model within the same parent network.

Regional players

  • PharmaTimes: UK-based B2B pharma publication covering manufacturing, clinical development, and industry trends including CGT. Comparable B2B media format but primarily focused on European audiences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Cell & Gene social profiles

Digital presence

Cell & Gene financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cell & Gene leadership team

Management profile

Number of profiles

Cell & Gene funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cell & Gene M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell & Gene

What does Cell & Gene do?

Cell & Gene is a B2B media and content platform dedicated to the cell and gene therapy industry. It publishes editorial articles, technical guides, white papers, a weekly email newsletter, on-demand video content, a podcast, and live virtual events, and hosts an annual expo plus Sourcing Center B2B directories for clinical trials, manufacturing, regulatory, supply chain, outsourcing, and translational research services. Revenue is generated through advertising, sponsorships, and event participation by CDMOs, equipment manufacturers, and life science service providers targeting CGT professionals.

Is Cell & Gene a public or private company?

Cell & Gene is a private company. It is classified as corporate owned and is currently operating.

When was Cell & Gene founded?

Cell & Gene was founded in 1996. It employs 1 to 10 people.

Where is Cell & Gene based?

Cell & Gene is headquartered in Erie, United States, in the North America region.

How does Cell & Gene make money?

Three revenue lines are on record. Advertising & Sponsorship Revenue is the primary driver. The others are newsletter Subscription (Free to Readers) and event Sponsorships and Registrations.

Who are Cell & Gene's main competitors?

Direct peers on record are Endpoints News, GEN (Genetic Engineering & Biotechnology News), BioPharma Dive, Fierce Biotech, BioSpace and BioProcess International (BPI). Broad incumbents are Outsourced Pharma, Drug Discovery Online and Life Science Leader. PharmaTimes is listed as a regional player.

Does Cell & Gene have an API?

No public API is recorded for Cell & Gene.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales